A NIBR postdoctoral fellowship leads to the discovery of a key genetic mutation behind a form of blindness.
Cataracts are a serious but common eye condition affecting more than 20 million worldwide. A patient in Brazil tells her story.
Sandoz, the generic division of Novartis, is working with a local partner in Brazil which is undertaking the first clinical trial in that country for a biosimilar drug.
GNF head spent career making scientific discoveries in academia. Read how he now he plans to evolve drug discovery in industry.
As the Ebola outbreak in West Africa continues to expand with isolated cases now being reported in Europe and North America, Novartis and its employees are contributing aid and pursuing research to help fight the deadly virus.
Interview with Mahesh P. Karande, Head of the Africa Cluster for Novartis. In this role, he is responsible for leading Novartis business activities in sub-Saharan Africa.
Drug discovery is field for creative people who want challenges. See why NIBR President Mark Fishman puts patients first in biomedical research.
John Hadcock’s wife Laura gave him an ultimatum: Run the energy out of Sunny, the new puppy, or take her back to the breeder. So Hadcock started running. On his first trip out, he had to stop half a mile in.
By improving access to healthcare in remote areas of developing countries, SMS for Life is making a real difference in the lives of people with malaria and other diseases.
Review the strategy and annual performance of Novartis and read letters from our Chairman and CEO.
This site is intended for a global audience.